Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulio Russo

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
Nature Communications|March 12, 2021
SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interfaceFederico Bertoglio, Doris Meier, Nora Langreder, et al.
International Journal of Cardiology|March 4, 2024
Effects of tricuspid transcatheter edge-to-edge repair on tricuspid annulus diameter - Data from the TriValve registryGiulio Russo, Rebecca T Hahn, Hannes Alessandrini, et al.
European Heart Journal. Cardiovascular Imaging|August 27, 2024
Mitral regurgitation evolution after transcatheter tricuspid valve interventions-a sub-analysis of the TriValve registryFrancesco Cannata, Alessandro Sticchi, Giulio Russo, et al.
JACC. Cardiovascular Interventions|May 16, 2024
Prognostic Implications of Residual Tricuspid Regurgitation Grading After Transcatheter Tricuspid Valve RepairJulien Dreyfus, Maurizio Taramasso, Karl-Patrik Kresoja, et al.
International Journal of Cardiology|March 11, 2025
Right heart failure and mortality in patients undergoing transcatheter tricuspid valve interventionsEdoardo Pancaldi, Marianna Adamo, Matteo Pagnesi, et al.
European Journal of Heart Failure|October 31, 2023
Characteristics and outcomes of patients with atrial versus ventricular secondary tricuspid regurgitation undergoing tricuspid transcatheter edge-to-edge repair - Results from the TriValve registryGiulio Russo, Luigi P Badano, Marianna Adamo, et al.
Cell Reports|July 17, 2021
A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutationsFederico Bertoglio, Viola Fühner, Maximilian Ruschig, et al.
Circulation. Cardiovascular Interventions|March 26, 2026
Impact of Proportionality of Secondary Tricuspid Regurgitation on Outcomes After Tricuspid Transcatheter Edge-to-Edge RepairGiulio Russo, Daniela Pedicino, Marianna Adamo, et al.
JACC. Cardiovascular Interventions|September 25, 2024
TRIVALVE Score: A Risk Score for Mortality/Hospitalization Prediction in Patients Undergoing Transcatheter Tricuspid Valve InterventionGiulio Russo, Daniela Pedicino, Denise Pires Marafon, et al.
European Journal of Heart Failure|August 31, 2025
Left ventricular ejection fraction and benefit of tricuspid valve interventions - insights from the international TRIGISTRYGregor Heitzinger, Julien Dreyfus, Varius Dannenberg, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Nature Communications|March 12, 2021
SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interfaceFederico Bertoglio, Doris Meier, Nora Langreder, et al.
International Journal of Cardiology|March 4, 2024
Effects of tricuspid transcatheter edge-to-edge repair on tricuspid annulus diameter - Data from the TriValve registryGiulio Russo, Rebecca T Hahn, Hannes Alessandrini, et al.
European Heart Journal. Cardiovascular Imaging|August 27, 2024
Mitral regurgitation evolution after transcatheter tricuspid valve interventions-a sub-analysis of the TriValve registryFrancesco Cannata, Alessandro Sticchi, Giulio Russo, et al.
JACC. Cardiovascular Interventions|May 16, 2024
Prognostic Implications of Residual Tricuspid Regurgitation Grading After Transcatheter Tricuspid Valve RepairJulien Dreyfus, Maurizio Taramasso, Karl-Patrik Kresoja, et al.
International Journal of Cardiology|March 11, 2025
Right heart failure and mortality in patients undergoing transcatheter tricuspid valve interventionsEdoardo Pancaldi, Marianna Adamo, Matteo Pagnesi, et al.
European Journal of Heart Failure|October 31, 2023
Characteristics and outcomes of patients with atrial versus ventricular secondary tricuspid regurgitation undergoing tricuspid transcatheter edge-to-edge repair - Results from the TriValve registryGiulio Russo, Luigi P Badano, Marianna Adamo, et al.
Cell Reports|July 17, 2021
A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutationsFederico Bertoglio, Viola Fühner, Maximilian Ruschig, et al.
Circulation. Cardiovascular Interventions|March 26, 2026
Impact of Proportionality of Secondary Tricuspid Regurgitation on Outcomes After Tricuspid Transcatheter Edge-to-Edge RepairGiulio Russo, Daniela Pedicino, Marianna Adamo, et al.
JACC. Cardiovascular Interventions|September 25, 2024
TRIVALVE Score: A Risk Score for Mortality/Hospitalization Prediction in Patients Undergoing Transcatheter Tricuspid Valve InterventionGiulio Russo, Daniela Pedicino, Denise Pires Marafon, et al.
European Journal of Heart Failure|August 31, 2025
Left ventricular ejection fraction and benefit of tricuspid valve interventions - insights from the international TRIGISTRYGregor Heitzinger, Julien Dreyfus, Varius Dannenberg, et al.
Pageof 11